Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousBone MarrowStem Cell TransplantationTransplantation ConditioningBone Marrow CellsWhole-Body IrradiationTransplantation ChimeraLiver TransplantationHematologic NeoplasmsTissue DonorsGraft SurvivalPeripheral Blood Stem Cell TransplantationLeukemiaBusulfanHistocompatibility TestingStem CellsHistocompatibilityAnemia, AplasticTreatment OutcomeHematopoiesisKidney TransplantationRecurrenceTransplantation, IsogeneicCord Blood Stem Cell TransplantationImmunosuppressive AgentsCombined Modality TherapyCyclophosphamideRetrospective StudiesRemission InductionLeukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseTransplantation ImmunologyTime FactorsMice, Inbred C57BLGraft vs Leukemia EffectBone Marrow PurgingAntigens, CD34Graft RejectionHematopoietic Stem Cell MobilizationHLA AntigensLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloablative AgonistsHematologic DiseasesChimerismPrecursor Cell Lymphoblastic Leukemia-LymphomaHeart TransplantationMyelodysplastic SyndromesCell DifferentiationSurvival AnalysisSevere Combined ImmunodeficiencyBone and BonesCell TransplantationSurvival RateImmunosuppressionLymphocyte DepletionLung TransplantationColony-Forming Units AssayLymphocyte TransfusionGraft vs Tumor EffectMultiple MyelomaAcute DiseaseBone Marrow DiseasesDisease-Free SurvivalLymphoma, Non-HodgkinRadiation ChimeraT-LymphocytesMelphalanLeukemia, MyeloidOrgan TransplantationMesenchymal Stem Cell TransplantationFlow CytometryCytomegalovirus InfectionsFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorCell LineageAntilymphocyte SerumCyclosporineSiblingsTransplantationCells, CulturedVidarabineLeukocyte TransfusionCytarabineSalvage TherapyUnrelated DonorsBone Marrow ExaminationGraft vs Host ReactionPrognosisCell SeparationOpportunistic InfectionsFetal BloodChimeraLiving DonorsInfection